JP2013126995A5 - - Google Patents

Download PDF

Info

Publication number
JP2013126995A5
JP2013126995A5 JP2013027479A JP2013027479A JP2013126995A5 JP 2013126995 A5 JP2013126995 A5 JP 2013126995A5 JP 2013027479 A JP2013027479 A JP 2013027479A JP 2013027479 A JP2013027479 A JP 2013027479A JP 2013126995 A5 JP2013126995 A5 JP 2013126995A5
Authority
JP
Japan
Prior art keywords
seq
helix
amino acid
isolated polypeptide
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013027479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013126995A (ja
JP5918155B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013126995A publication Critical patent/JP2013126995A/ja
Publication of JP2013126995A5 publication Critical patent/JP2013126995A5/ja
Application granted granted Critical
Publication of JP5918155B2 publication Critical patent/JP5918155B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013027479A 2005-08-05 2013-02-15 組織保護ペプチド及びその使用 Expired - Fee Related JP5918155B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US70574105P 2005-08-05 2005-08-05
US60/705,741 2005-08-05
US70627605P 2005-08-08 2005-08-08
US60/706,276 2005-08-08
US83173706P 2006-07-18 2006-07-18
US60/831,737 2006-07-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008525285A Division JP5274253B2 (ja) 2005-08-05 2006-08-07 組織保護ペプチド及びその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015020020A Division JP6158235B2 (ja) 2005-08-05 2015-02-04 組織保護ペプチド及びその使用

Publications (3)

Publication Number Publication Date
JP2013126995A JP2013126995A (ja) 2013-06-27
JP2013126995A5 true JP2013126995A5 (https=) 2013-08-08
JP5918155B2 JP5918155B2 (ja) 2016-05-18

Family

ID=37728020

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2008525285A Expired - Fee Related JP5274253B2 (ja) 2005-08-05 2006-08-07 組織保護ペプチド及びその使用
JP2013027479A Expired - Fee Related JP5918155B2 (ja) 2005-08-05 2013-02-15 組織保護ペプチド及びその使用
JP2015020020A Expired - Fee Related JP6158235B2 (ja) 2005-08-05 2015-02-04 組織保護ペプチド及びその使用
JP2016114010A Expired - Fee Related JP6491621B2 (ja) 2005-08-05 2016-06-08 組織保護ペプチド及びその使用
JP2018071318A Pending JP2018134084A (ja) 2005-08-05 2018-04-03 組織保護ペプチド及びその使用
JP2020013151A Pending JP2020078317A (ja) 2005-08-05 2020-01-30 組織保護ペプチド及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008525285A Expired - Fee Related JP5274253B2 (ja) 2005-08-05 2006-08-07 組織保護ペプチド及びその使用

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015020020A Expired - Fee Related JP6158235B2 (ja) 2005-08-05 2015-02-04 組織保護ペプチド及びその使用
JP2016114010A Expired - Fee Related JP6491621B2 (ja) 2005-08-05 2016-06-08 組織保護ペプチド及びその使用
JP2018071318A Pending JP2018134084A (ja) 2005-08-05 2018-04-03 組織保護ペプチド及びその使用
JP2020013151A Pending JP2020078317A (ja) 2005-08-05 2020-01-30 組織保護ペプチド及びその使用

Country Status (25)

Country Link
US (7) US8071554B2 (https=)
EP (5) EP1924276A4 (https=)
JP (6) JP5274253B2 (https=)
KR (7) KR101626153B1 (https=)
CN (2) CN101378772B (https=)
AU (1) AU2006278264B2 (https=)
BR (1) BRPI0614529A8 (https=)
CA (3) CA2618396C (https=)
DK (3) DK2371855T3 (https=)
EA (1) EA015672B1 (https=)
ES (3) ES2653864T3 (https=)
HU (3) HUE035793T2 (https=)
IL (3) IL189287A (https=)
IN (1) IN2014CN02050A (https=)
LT (2) LT2594279T (https=)
MX (3) MX364100B (https=)
NO (1) NO20081112L (https=)
NZ (1) NZ565937A (https=)
PL (3) PL2371855T3 (https=)
PT (3) PT2540309T (https=)
SG (2) SG2014007868A (https=)
SI (3) SI2540309T1 (https=)
UA (1) UA100222C2 (https=)
WO (1) WO2007019545A2 (https=)
ZA (1) ZA201101890B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
WO2007052154A2 (en) 2005-04-29 2007-05-10 University Of Medicine And Dentistry Of New Jersey Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
US9345745B2 (en) 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
US9585932B2 (en) * 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
SI2540309T1 (en) 2005-08-05 2018-04-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and their uses
BRPI0712063A2 (pt) * 2006-06-07 2011-12-20 Chugai Pharmaceutical Co Ltd tratamento de doenças isquêmicas usando eritropoietina
WO2008058942A2 (en) * 2006-11-13 2008-05-22 Charite - Universitätsmedezin Berlin Method of cell culture and method of treatment comprising a vepo protein variant
AU2016203452B2 (en) * 2008-01-22 2018-02-22 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
AU2014203195B2 (en) * 2008-01-22 2016-03-31 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
KR20200075044A (ko) * 2008-01-22 2020-06-25 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
US8791234B2 (en) * 2010-10-14 2014-07-29 Rutgers, The State University Of New Jersey Intestinal peptide targeting ligands
US9566349B2 (en) * 2010-10-14 2017-02-14 Rutgers, The State University Of New Jersey Intestinal peptide targeting ligands
CN102180948A (zh) * 2011-03-03 2011-09-14 复旦大学附属中山医院 一种具有肾脏保护作用的短肽及其制备方法和应用
CN102212111B (zh) * 2011-05-05 2014-04-30 中国人民解放军第三军医大学 小分子多肽和小分子多肽脂质体及其运用
CA2843014C (en) * 2011-07-27 2020-01-21 Neumedicines, Inc. Use of il-12 to generate endogenous erythropoietin
US20140249573A1 (en) * 2011-09-20 2014-09-04 A.A. Cash Technology Ltd. Methods and devices for occluding blood flow to an organ
KR101148191B1 (ko) * 2011-09-27 2012-05-23 김후정 에리스로포이에틴-유래 펩타이드 및 그 용도
WO2013158871A1 (en) * 2012-04-20 2013-10-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of erythropoietin and derivatives for treating hypertension
CA2918223A1 (en) * 2013-07-17 2015-01-22 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
CN104744593A (zh) * 2013-12-25 2015-07-01 深圳先进技术研究院 一种抗肿瘤血管生成免疫复合肽及其制备方法和应用
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
CN106032389A (zh) * 2014-06-22 2016-10-19 马恒标 组织保护活性多肽sl6及其应用
CA3001065A1 (en) * 2015-10-14 2017-04-20 Xiaoxi WEI Compositions and methods for reducing ice crystal formation
JP2019523633A (ja) 2016-04-29 2019-08-29 アライム ファーマシューティカルズ，インコーポレーテッド 組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド
JP7167019B2 (ja) * 2016-11-10 2022-11-08 エーエスシー・リジェニティー・リミテッド エリスロポエチン由来分子を含む局所適用のための美容用製剤
CN110475786A (zh) 2017-02-27 2019-11-19 大邱庆北科学技术院 红细胞生成素衍生肽通过其对预防细胞损伤的作用的用途
CN108503690B (zh) * 2017-02-28 2020-07-03 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
US11260101B2 (en) 2017-02-28 2022-03-01 Jinan University Repair peptide for use in promoting post-traumatic tissue repair and regeneration, and application thereof
JP7481261B2 (ja) * 2018-04-08 2024-05-10 ブリム バイオテクノロジー インク 腱治癒に対するｐｅｄｆ由来短鎖ペプチドの使用
KR102300060B1 (ko) 2018-06-12 2021-09-08 주식회사 엘지에너지솔루션 2열 터미널 구조의 pcb 다이렉트 커넥터
MX2021002761A (es) 2018-09-10 2021-05-31 Cold Spring Harbor Laboratory Metodos para tratar la pancreatitis.
CN112390877B (zh) * 2019-08-16 2022-10-04 董红燕 Pedf衍生多肽组合物及其在制备保护肺损伤药物中的应用
CN118255845B (zh) * 2022-12-27 2025-07-11 上海瑞吉康生物医药有限公司 相分离逆转多肽的变体及其应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
US4558006A (en) 1983-02-04 1985-12-10 Kirin-Amgen, Inc. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
US5051448A (en) 1984-07-24 1991-09-24 The Mclean Hospital Corporation GABA esters and GABA analog esters
US4704355A (en) 1985-03-27 1987-11-03 New Horizons Diagnostics Corporation Assay utilizing ATP encapsulated within liposome particles
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5498694A (en) 1989-05-25 1996-03-12 La Jolla Cancer Research Foundation Peptides of the cytoplasmic domain of integrin
DE3924746A1 (de) 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
WO1991004014A1 (en) 1989-09-21 1991-04-04 Synergen, Inc. Method for transporting compositions across the blood brain barrier
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US6140120A (en) * 1993-02-12 2000-10-31 Board Of Trustees Of Leland Stanford Jr. University Regulated transcription of targeted genes and other biological events
US5559103A (en) 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US5700909A (en) 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
WO1995021919A2 (en) * 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
ITFI940106A1 (it) * 1994-05-27 1995-11-27 Menarini Ricerche Sud Spa Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica
US5576423A (en) 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
CA2223833C (en) * 1995-06-07 2010-12-21 Nicholas C. Wrighton Compounds and peptides that bind to the erythropoietin receptor
AU4267297A (en) * 1997-09-11 1998-09-22 Regents Of The University Of California, The Method of alleviating neuropathic pain
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US7270809B2 (en) * 1997-07-14 2007-09-18 Bolder Biotechnology, Inc. Cysteine variants of alpha interferon-2
KR101012932B1 (ko) 1999-04-13 2011-02-08 더 케네쓰 에스. 워렌 인스티튜트 인코포레이티드 말초 투여된 에리트로포에틴에 의한 흥분조직의 기능조절법
AU2001252650A1 (en) * 2000-04-28 2001-11-12 Effector Cell Institute Novel derivative of cell chemotactic factor
AU2002233230B2 (en) * 2000-12-20 2007-02-01 F. Hoffmann-La Roche Ag Erythropoietin conjugates
PA8536201A1 (es) 2000-12-29 2002-08-29 Kenneth S Warren Inst Inc Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US20040063917A1 (en) * 2001-02-06 2004-04-01 Carr Francis J. Modified erythropoietin (epo) with reduced immunogenicity
CA2443373A1 (en) * 2001-04-04 2002-10-31 Genodyssee New polynucleotides and polypeptides of the erythropoietin gene
KR100467751B1 (ko) * 2001-12-03 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
EP1552298A4 (en) 2002-07-01 2006-11-08 Kenneth S Warren Inst Inc RECOMBINANT TISSUE-PROOFING CYTOKINS AND NUCLEIC ACIDS COORDINATING THEREOF FOR THE PROTECTION, RECOVERY AND IMPROVEMENT OF CELLS, TISSUE AND ORGANS THEREOF
KR100478455B1 (ko) 2002-08-19 2005-03-22 삼성전자주식회사 전자렌지
WO2004022577A2 (en) 2002-09-09 2004-03-18 Warren Pharmaceuticals, Inc. Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
WO2005025606A1 (en) 2003-09-09 2005-03-24 Warren Pharmaceuticals, Inc. Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
CA2500715A1 (en) * 2002-10-03 2004-04-15 Epimmune Inc. Hla binding peptides and their uses
JP2004305006A (ja) * 2003-04-01 2004-11-04 Japan Science & Technology Agency 人工調製肺サーファクタント
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
CN103230415B (zh) * 2003-04-25 2016-05-04 匹兹堡大学联邦制高等教育 用于促进和增强神经修复和再生的肌肉来源的细胞（mdc）
WO2005032467A2 (en) 2003-09-29 2005-04-14 Warren Pharmaceuticals, Inc. Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
US7842661B2 (en) 2003-11-24 2010-11-30 Novo Nordisk A/S Glycopegylated erythropoietin formulations
US20080227696A1 (en) * 2005-02-22 2008-09-18 Biosurface Engineering Technologies, Inc. Single branch heparin-binding growth factor analogs
WO2007010552A2 (en) 2005-03-17 2007-01-25 Serum Institute Of India Limited N- terminal peg conjugate of erythropoietin
US9345745B2 (en) 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
WO2007052154A2 (en) 2005-04-29 2007-05-10 University Of Medicine And Dentistry Of New Jersey Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
EP2385061A3 (en) 2005-05-10 2012-02-22 Neoloch Aps Neuritogenic peptides
EP1736481A1 (en) 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietin variants
SI2540309T1 (en) * 2005-08-05 2018-04-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and their uses
ES2386495T3 (es) 2007-11-29 2012-08-21 Molecular Health Gmbh siARN específico de EPH-B4 para reducir el crecimiento de células neoplásicas inducidas por EPO durante el tratamiento de anemia en pacientes con cáncer, receptor de eritropoyetina protector de tejido (NEPOR) y métodos de uso
KR20200075044A (ko) 2008-01-22 2020-06-25 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
JP2011523353A (ja) * 2008-04-28 2011-08-11 プレジデント アンド フェロウズ オブ ハーバード カレッジ 細胞透過のための過剰に荷電されたタンパク質
WO2011022056A2 (en) 2009-08-18 2011-02-24 Medical College Of Georgia Research Institute, Inc. PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2013126995A5 (https=)
JP2009508471A5 (https=)
US20210269506A1 (en) Polynucleotides encoding immune modulating polypeptides
SI2594279T1 (en) Tissue protective peptides and their uses
RU2648950C2 (ru) Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
JP2020040969A5 (https=)
WO2009100253A8 (en) Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein
JP2022541657A5 (https=)
JP2016196480A5 (https=)
US9688733B2 (en) Method for treating spinal cord injury using HMGB1 fragment
BR112021003410A2 (pt) anticorpos de domínio único anti-bcma, grupo de genes dos ditos anticorpos, polipeptídeo, vetor de expressão, célula hospedeira, receptor de antígeno quimérico, célula t modificada pelo mesmo, composição farmacêutica e usos dos ditos anticorpos
JP2018522579A5 (https=)
CN105327350A (zh) 泛素化途径相关因子在调控辅助性t细胞功能中的应用
Wang et al. High level expression and purification of bioactive human α-defensin 5 mature peptide in Pichia pastoris
CN114573709B (zh) 携带趋化因子受体且靶向msln抗原的car t免疫细胞的制备及其用途
JP2016514672A (ja) 抗原およびアジュバントとしてのインターロイキン−２３を有するワクチン
JP2003189887A5 (https=)
EP2412723B1 (en) Modified sodium iodide symporter proteins and uses thereof
CN114438106B (zh) Rv2779c基因及其表达产物作为抗结核分枝杆菌靶点的应用
ES2390967T3 (es) Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización
JP2018535684A5 (https=)
CN109200271A (zh) 一种蛋白质及其在调控巨噬细胞免疫功能方面的应用
JP2009542631A (ja) 自己免疫疾患、アレルギー性疾患及び炎症性疾患治療用薬剤組成物、並びにその伝達方法
CN106552259A (zh) 一种融合蛋白及其治疗疾病的用途
JP2021516668A5 (https=)